Innate Pharma Files 6-K, Reports Press Release
Ticker: IPHYF · Form: 6-K · Filed: Aug 4, 2025 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, press-release, foreign-issuer
TL;DR
Innate Pharma dropped a 6-K with a press release on Aug 4. Check the release for news.
AI Summary
Innate Pharma S.A. filed a Form 6-K on August 4, 2025, reporting a press release dated August 4, 2025. The company, headquartered in Marseille, France, is a foreign private issuer and files annual reports under Form 20-F. This filing does not contain specific financial figures or operational details beyond the reporting of the press release.
Why It Matters
This filing indicates Innate Pharma is providing updated information to the SEC, likely containing material news for investors. Investors should review the referenced press release for details.
Risk Assessment
Risk Level: low — This is a routine filing to report a press release and does not contain new financial or operational risks.
Key Players & Entities
- Innate Pharma S.A. (company) — Registrant
- August 4, 2025 (date) — Filing Date and Press Release Date
- Marseille, France (location) — Company Headquarters
- Form 6-K (document) — SEC Filing Type
- Form 20-F (document) — Annual Report Filing
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated August 4, 2025, issued by Innate Pharma S.A.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on Monday, August 4, 2025.
Where is Innate Pharma S.A. headquartered?
Innate Pharma S.A. is headquartered at 117 Avenue de Luminy, BP 30191, 13009 Marseille, France.
Does Innate Pharma S.A. file annual reports under Form 20-F or 40-F?
Innate Pharma S.A. files its annual reports under cover of Form 20-F.
What exhibit is included with this Form 6-K filing?
Exhibit 99.1, a Press Release dated August 4, 2025, is included with this Form 6-K filing.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 4, 2025 regarding Innate Pharma SA (IPHYF).